Topics

Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019

17:05 EST 7 Nov 2019 | FinanzNachrichten

Conference call and webcast on Friday, November 8 at 2:30 pm CET/8:30 am ETTRYbeCA1, Phase 3 trial of eryaspase in second line pancreatic cancer: positive safety review by independent data monitori...

Original Article: Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019

NEXT ARTICLE

More From BioPortfolio on "Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019"

Quick Search

Relevant Topics

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...